CoChat

The future of psychopharmacology of depression.

Chang, Trina, Fava, Maurizio · 2010 · The Journal of Clinical Psychiatry

The DOI matches its Crossref record.

Abstract

Article AbstractThere are clear limitations to the currently approved pharmacotherapies of depression, including the fact that they are all essentially monoamine-based, have modest efficacy and a relatively slow onset of efficacy, and suffer from significant tolerability issues, particularly in the long term, including sexual dysfunction, weight gain, and cognitive impairments. This article reviews some of the most promising novel mechanisms that are not represented in compounds currently approved for depression in either the United States or Europe and that may represent the future of the psychopharmacologic treatment of depression, potentially addressing some of the efficacy and tolerability issues of antidepressants on the market. These potential antidepressant treatments include the multimodal serotonergic agents, the triple uptake inhibitors, the neurokinin-based novel therapies, the glutamatergic treatments, the nicotinic receptor-based treatments, the neurogenesis-based treatments, and antiglucocorticoid therapies. Some of these mechanisms appear to be more advanced in terms of drug development than others, but they all contribute to the global effort to develop more effective and better tolerated treatments for major depressive disorder.J Clin Psychiatry 2010;71(8):971-975Submitted: May 5, 2010; accepted June 17, 2010 (doi:10.4088/JCP.10m06223blu). Corresponding author: Maurizio Fava, MD, Depression Clinical and Research Program, Massachusetts General Hospital, 55 Fruit St, Bulfinch 351, Boston, MA 02114 (MFava@Partners.org).

Overview

Integrity signals

Registry

Crossref · 10.4088/jcp.10m06223blu

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cited by

See all 51

Metadata

Authors
Chang, T., & Fava, M.
Affiliations
Massachusetts General Hospital (US)
Venue
The Journal of Clinical Psychiatry
Published
2010-08-15
Volume
71
Issue
08
Pages
971-975
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2034147634
Cited by
50
References
0
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 2 · 2012: 9
FWCI
5.43
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (T32MH19126, T32MH019126)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
depression, antidepressants, major depressive disorder, neurokinin receptor antagonists, nicotinic agonists, antidepressant tolerability, sexual dysfunction, weight gain, cognitive impairment
MeSH terms
Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Depressive Disorder, Europe, Humans, Psychopharmacology, United States, Treatment Outcome, Drug Approval, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The future of psychopharmacology of depression. https://app.cochat.ai/papers/10.4088/jcp.10m06223blu
The paper
Chang, T., & Fava, M. (2010). The future of psychopharmacology of depression. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.10m06223blu

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.